Emergen research’s latest document, titled ‘Biodefense market’ is one of the most sought-after market reports involving an in-depth analysis of the global Biodefense market. The report’s authors have offered necessary details on the latest Biodefense market trends and the crucial parameters impacting both short-term and long-term market growth.
The global biodefense market size is expected to reach USD 20.13 Billion in 2028 and register a revenue CAGR of 5.4% over the forecast period, according to the latest report by Emergen Research. Favorable government initiatives, increasing possibility of biological threats and attacks are factors driving global biodefense market revenue growth.
Biodefense is the use of medical measures to protect citizens against bioterrorism threats or possibility. Biodefense also includes production of stockpiles of vaccines and medication for people across the globe. Bioterrorism is an intentional release of harmful biological agents such as bacteria, viruses, and other germs to cause sickness/illness, and to harm humans, animals, or crops in a country or region. Biological agents can spread through air, water, food, and contact, and can ruin food crops and infect or kill livestock to terrorize populations or to manipulate governments.
Click the link to get info@ https://www.emergenresearch.com/industry-report/biodefense-market
Key Points of Biodefense Market:
Major companies included in the global market report are CanSino Biologics, BioNTech SE, Altimmune, Emergent BioSolutions Inc., SIGA Technologies, Inc., Cleveland BioLabs, Inc., Alnylam Pharmaceuticals Inc., Elusys Therapeutics, DynPort Vaccine Company LLC, and Ichor Medical Systems Inc., AstraZeneca Plc, Serum Institute of India, Wuhan Institute of Biological Products, Inovio Pharmaceuticals Inc., and SinovacBiotech Ltd.
Radical Highlights of the Biodefense Market Report:
Emergen Research has segmented the global biodefense market on the basis of product type, biothreat detection device type, end-use, and region:
Product Type Outlook (Revenue, USD Billion; 2018–2028)
Biothreat Detection Device Type Outlook (Revenue, USD Billion; 2018-2028)
End-use Outlook (Revenue, USD Billion; 2018–2028)
Some Key Highlights from the Report
Thank you for reading our report. Customization of the report is available. To know more, please connect with us, and our team will ensure the report is customized as per your requirements.
Take a Look at our Related Reports:
next-generation sequencing market
in-vitro fertilization market
companion diagnostics market
ai-based sensors market
follicular lymphoma treatment market
blockchain in healthcare market
next generation sequencing sample preparation market
pharmacogenomics market
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Overview and Scope Plasma powder is a protein-rich ingredient derived from the spray-drying of plasma,…
Overview and Scope A pedestrian bridge is a constructed framework spanning a railway, river, or…
Overview and Scope Next-generation antibody therapeutics are advanced antibody-based drugs in structure, functionality, and therapeutic…
Overview and Scope A neurological biomarker is a substance that provides objective and quantifiable information…
Overview and Scope Home insurance is a policy that pays for expenses and damage to…
Overview and Scope Extended-release drugs are a dosage form made to release the medication over…